266 related articles for article (PubMed ID: 35917826)
21. Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trial.
Mascalchi M; Romei C; Marzi C; Diciotti S; Picozzi G; Pistelli F; Zappa M; Paci E; Carozzi F; Gorini G; Falaschi F; Deliperi AL; Camiciottoli G; Carrozzi L; Puliti D
Eur Radiol; 2023 May; 33(5):3115-3123. PubMed ID: 36854875
[TBL] [Abstract][Full Text] [Related]
22. The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline Round.
Antonicelli A; Muriana P; Favaro G; Mangiameli G; Lanza E; Profili M; Bianchi F; Fina E; Ferrante G; Ghislandi S; Pistillo D; Finocchiaro G; Condorelli G; Lembo R; Novellis P; Dieci E; De Santis S; Veronesi G
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254906
[TBL] [Abstract][Full Text] [Related]
23. Queensland Lung Cancer Screening Study: rationale, design and methods.
Marshall HM; Bowman RV; Crossin J; Lau MA; Slaughter RE; Passmore LH; McCaul EM; Courtney DA; Windsor MN; Yang IA; Smith IR; Keir BJ; Hayes TJ; Redmond SJ; Zimmerman PV; Fong KM
Intern Med J; 2013 Feb; 43(2):174-82. PubMed ID: 22471951
[TBL] [Abstract][Full Text] [Related]
24. Improving selection criteria for lung cancer screening. The potential role of emphysema.
Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
[TBL] [Abstract][Full Text] [Related]
25. Low-dose Lung Cancer Screening at an Academic Medical Center: Initial Experience and Dose Reduction Strategies.
Ahmed A; Verma N; Barreto I; Mohammed TL
Acad Radiol; 2018 Aug; 25(8):1025-1030. PubMed ID: 29395799
[TBL] [Abstract][Full Text] [Related]
26. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
[TBL] [Abstract][Full Text] [Related]
27. Organized Lung Cancer Screening Pilot: Informing a Province-Wide Program in Ontario, Canada.
Darling GE; Tammemägi MC; Schmidt H; Buchanan DN; Leung Y; McGarry C; Rabeneck L
Ann Thorac Surg; 2021 Jun; 111(6):1805-1811. PubMed ID: 33039364
[TBL] [Abstract][Full Text] [Related]
28. Lung Cancer Screening by Low-Dose Computed Tomography - Part 1: Expected Benefits, Possible Harms, and Criteria for Eligibility and Population Targeting.
Kaaks R; Delorme S
Rofo; 2021 May; 193(5):527-536. PubMed ID: 33212540
[TBL] [Abstract][Full Text] [Related]
29. The effect of radiographic emphysema in assessing lung cancer risk.
Yong PC; Sigel K; de-Torres JP; Mhango G; Kale M; Kong CY; Zulueta JJ; Wilson D; Brown SW; Slatore C; Wisnivesky J
Thorax; 2019 Sep; 74(9):858-864. PubMed ID: 30723183
[TBL] [Abstract][Full Text] [Related]
30. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
Silva M; Pastorino U; Sverzellati N
Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
[TBL] [Abstract][Full Text] [Related]
31. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
32. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
33. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.
Tanner NT; Kanodra NM; Gebregziabher M; Payne E; Halbert CH; Warren GW; Egede LE; Silvestri GA
Am J Respir Crit Care Med; 2016 Mar; 193(5):534-41. PubMed ID: 26502000
[TBL] [Abstract][Full Text] [Related]
34. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.
Wiener RS; Gould MK; Arenberg DA; Au DH; Fennig K; Lamb CR; Mazzone PJ; Midthun DE; Napoli M; Ost DE; Powell CA; Rivera MP; Slatore CG; Tanner NT; Vachani A; Wisnivesky JP; Yoon SH;
Am J Respir Crit Care Med; 2015 Oct; 192(7):881-91. PubMed ID: 26426785
[TBL] [Abstract][Full Text] [Related]
35. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).
Sanchez-Salcedo P; Berto J; de-Torres JP; Campo A; Alcaide AB; Bastarrika G; Pueyo JC; Villanueva A; Echeveste JI; Lozano MD; García-Velloso MJ; Seijo LM; García J; Torre W; Pajares MJ; Pío R; Montuenga LM; Zulueta JJ
Arch Bronconeumol; 2015 Apr; 51(4):169-76. PubMed ID: 25641356
[TBL] [Abstract][Full Text] [Related]
36. The Swiss Approach - feasibility of a national low-dose CT lung cancer screening program.
Jungblut L; von Garnier C; Puhan M; Tomonaga Y; Kaufmann C; Azzola A; Bürgi U; Bremerich J; Brutsche M; Christe A; Ebner L; Heverhagen JT; Eich C; Franzen D; Schmitt-Opitz I; Schneiter D; Spieldenner J; Horwath N; Kohler M; Weder W; Lovis A; Meuli R; Menig M; Beigelmann-Aubry C; Niemann T; Stöhr S; Vock P; Senn O; Neuner-Jehle S; Selby K; Laures S; Ott S; Frauenfelder T
Swiss Med Wkly; 2022 Apr; 152(15-16):. PubMed ID: 35633633
[TBL] [Abstract][Full Text] [Related]
37. Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program.
Kerpel-Fronius A; Monostori Z; Kovacs G; Ostoros G; Horvath I; Solymosi D; Pipek O; Szatmari F; Kovacs A; Markoczy Z; Rojko L; Renyi-Vamos F; Hoetzenecker K; Bogos K; Megyesfalvi Z; Dome B
Eur Radiol; 2022 Jul; 32(7):4457-4467. PubMed ID: 35247089
[TBL] [Abstract][Full Text] [Related]
38. Visual scoring of aortic valve calcifications on low-dose CT in lung cancer screening.
Zhu Y; Wang Y; Gioia WE; Yip R; Jirapatnakul AC; Chung MS; Yankelevitz DF; Henschke CI
Eur Radiol; 2020 May; 30(5):2658-2668. PubMed ID: 32040729
[TBL] [Abstract][Full Text] [Related]
39. Significant Incidental Findings in the National Lung Screening Trial.
Gareen IF; Gutman R; Sicks J; Tailor TD; Hoffman RM; Trivedi AN; Flores E; Underwood E; Cochancela J; Chiles C
JAMA Intern Med; 2023 Jul; 183(7):677-684. PubMed ID: 37155190
[TBL] [Abstract][Full Text] [Related]
40. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
